Medicines are of great value to health care and society. ZonMw research into existing medicines is directed towards their more effective, more efficient, and safer use in day-to-day health care. Widespread dissemination and practical application of the generated knowledge is crucial to delivering health benefits to patients, improving the quality of care, and saving unnecessary costs.
The optimal use of existing medicines is an innovative area of work that shows great promise for the coming years.
With effect from 1 January 2023, we have implemented several changes in the procedure for applying for funding for the module Knowledge infrastructure of our programme More Knowledge with Fewer Animals (Dutch acronym: MKMD). This concerns the modules ‘Realising systematic literature research for studies involving experimental animals’, ‘Publishing neutral/negative results from experiments involving animals’, and the workshop ‘ Systematic...
Fifteen researchers who have recently received their PhDs can do their research at foreign research institutes thanks to a Rubicon grant from NWO. The Rubicon programme gives young, highly promising researchers the opportunity to gain international research experience.
The schedule with the 2023 submission dates for the Talent Scheme (Veni, Vidi, Vici) has been confirmed. Some changes have been made in the procedures of the new rounds, all designed to further simplify and save both applicants' and reviewers' precious time.
31 research teams will be able to start their project thanks to funding from the ZonMw Competition round 2021, which has a total budget of €24.2 million. Each research team will receive an average of €750,000 for their project. Six of the research teams will receive an additional €250,000 for investment in infrastructure.
Using the potential from existing animal and cellular models and cohorts, including available data and biomaterial, for conducting large-scale OMICS approaches to unravel the interplay and interactions of molecules from multiple molecular levels driving disease pathogenesis.
Better understanding the complex and multi-factorial mechanisms of disease onset and progression as well as the corresponding influencing factors.
Translating the findings from Big Data analysis and multi-OMICS approaches to existing animal and cellular models, thereby enhancing the potential of these models.
Identification of new drug targets or novel starting points for pharmacological interventions and prevention.
Sharpening the current understanding of disease definition, thus leading to enhanced sub-classification and better patient stratification.
Are you interested in international collaboration? And would you like to contribute to the transformation of health and care systems in Europe with a research project or a practice-based initiative? Then join us at the launch of the first grant call of the international ‘Transforming Health and Care Systems’ (THCS) programme.
